ABC aired a special from Oprah Winfrey last night about how new GLP-1 drugs are helping patients and changing the perception of obesity as a disease rather than a failure of willpower, giving even more exposure to Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. Read the full article here.
NIHR annual report for 2024/25 has been published today, showcasing the impact of NIHR funded and supported research.
Hear from CEO @Lucy Chappell and find out about some of the ways NIHR research is:
changing lives
improving quality of…
A new wearable wristband could transform diabetes management by continuously tracking not just glucose, but also chemical and cardiovascular signals that affect disease progression and overall health. The technology was recently reported in Nature Biomedical Engineering.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us